Spero Therapeutics, Inc. (NASDAQ: SPRO), a pioneering biopharmaceutical company specializing in treatments for bacterial infections and rare diseases, experienced a remarkable pre-market surge on Thursday,
As of the last check, Spero Therapeutics Inc. (SPRO) shares were trading at $18.88, up 35.24% in premarket trading. As of Wednesday’s close, Spero was
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.